Search results
Antibiotics Do Not Provide Relief From Lower Respiratory Tract Infections, Study Finds
Forbes· 6 days agoA new study of 718 patients who sought treatment in U.S.-based primary and emergency care settings found that antibiotics were ineffective in providing symptomatic relief from lower respiratory ...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga· 3 days agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within the ViraxImmune T-Cell diagnostic platform for research-use-only (RUO) at the European Society ...
NIH RECOVER Makes Long COVID Data Easier to Access - Deidentified Data from Thousands of Adults with...
Sierra Sun Times· 2 days agoDeidentified data from thousands of adults with long COVID are now available to researchers. April...
Should You Worry About The Bird Flu? Here Are The Concerns
Forbes· 1 day agoYou may have heard the recent revelations that the H5N1 bird flu virus has been spreading among...
Study: Antibiotic use in patients hospitalized with COVID-19 appears to have no beneficial effect on...
Medical Xpress· 2 days agoThe findings underscore the need to discourage indiscriminate prescribing and improve antibiotic...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life Style via AOL· 6 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
The pandemic cost 7 million lives, but talks to prevent a repeat stall
Washington Post· 7 days agoThe costs of not reaching one? An unknown future pathogen could have far more devastating...
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
KTLA-TV Los Angeles· 4 days agoRALEIGH, N.C. and TEL-AVIV, Israel, April 24, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
Texas Biomed researching vaccines and treatments for highly pathogenic avian influenza
Newswise· 2 days agoResearchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains ...
The pandemic cost 7 million lives, but talks to prevent a repeat stall
Anchorage Daily News· 6 days agoThe costs of not reaching one? An unknown future pathogen could have far more devastating...